No Matches Found
No Matches Found
No Matches Found
Shalby Ltd. Hits 52-Week Low Amidst Ongoing Market Volatility and Sector Underperformance
Shalby Ltd., a small-cap company in the Hospital & Healthcare Services sector, reached a new 52-week low today, reflecting significant volatility. The stock has underperformed its sector and has seen a cumulative drop over the past four days, indicating ongoing challenges in the competitive healthcare market.
Shalby Reports Mixed Financial Results Amidst Sales Growth and Rising Interest Expenses
Shalby has reported its financial results for the quarter ending December 2024, showcasing a year-on-year growth in net sales to Rs 275.63 crore. However, the company faces challenges with a significant decline in profit before tax and an increase in interest expenses, indicating a mixed financial performance.
Shalby Ltd. Hits 52-Week Low Amidst Ongoing Market Volatility and Underperformance
Shalby Ltd., a small-cap company in the Hospital & Healthcare Services sector, has reached a new 52-week low, reflecting significant volatility and a 12.15% decline over the past eight days. The stock has underperformed its sector and is trading below key moving averages, indicating a bearish trend.
Shalby Ltd. Hits 52-Week Low Amidst Underperformance in Healthcare Sector
Shalby Ltd., a smallcap company in the hospital and healthcare services industry, has been experiencing a downward trend in its stock performance. On November 21, 2024, the stock hit a 52-week low and has seen a decline of -4.54% in the past three days. According to MarketsMOJO, the stock is currently rated as a 'Strong Sell' and has underperformed the Sensex's positive growth of 16.89% in the past year.
Shalby's Financial Results Show Negative Trends, MarketsMOJO Gives 'Strong Sell' Call
Shalby, a smallcap company in the hospital and healthcare services industry, has reported a negative financial performance for the quarter ending September 2024. The company's operating profit, profit before tax, and profit after tax have all seen a significant decline, while its interest costs and debt-equity ratio have increased. MarketsMOJO has given a 'Strong Sell' call for the company's stock.
Shalby Ltd. Hits 52-Week Low and Receives 'Strong Sell' Rating from MarketsMOJO
Shalby Ltd., a smallcap company in the hospital and healthcare services industry, hit a 52-week low on November 18, 2024. The stock opened with a gain of 2.07% but closed 2.65% lower, showing a volatile trading day. It has been given a 'Strong Sell' rating and is trading below its moving averages, indicating a downward trend.
Shalby Ltd. Hits 52-Week Low, Underperforms Sector Amid Bearish Trend
Shalby Ltd., a smallcap company in the hospital and healthcare services industry, has hit a 52-week low on November 14, 2024, with a stock price of Rs. 209.3. The company's performance has underperformed the sector and is currently trading below its moving averages, indicating a bearish trend. In the past year, the company has shown a negative performance compared to the overall market. Investors are advised to conduct their own research and seek professional advice before investing.
Shalby Ltd. Hits 52-Week Low, Shows High Volatility and 'Strong Sell' Rating
Shalby Ltd., a smallcap company in the hospital and healthcare services industry, has recently hit a 52-week low and has been on a downward trend for the past 5 days. The stock showed high volatility today and is currently trading lower than its moving averages. According to MarketsMOJO, the stock call is 'Strong Sell', indicating caution for investors.
Shalby Ltd. sees 7.6% rise in stock price, outperforms sector on October 28
Shalby Ltd., a smallcap company in the hospital and healthcare services industry, saw a 7.6% rise in its stock price on October 28, 2024. Despite a 'Strong Sell' recommendation from MarketsMOJO, the company has outperformed the sector by 6.86% today, with a significant increase in stock price and high volatility.
Shalby's Q2 Financial Results Show Negative Performance, Concerns for Investors
Shalby, a smallcap healthcare services company, has reported a negative performance in the quarter ending June 2024, with a score of -22 compared to -8 in the previous quarter. While net sales were the highest in the last five quarters, there are concerns about falling profits, increased interest costs, and a slower pace of selling inventory. Investors should carefully evaluate these factors before making any investment decisions.
Shalby . sees 7.65% rise in stock price, outperforms market and sector
Shalby ., a smallcap healthcare services company, has seen a 7.65% increase in its stock price on July 5th, 2024. This rise has been attributed to the company's strong performance in the market, with its stock outperforming its sector and the overall market. According to MarketsMOJO, Shalby .'s stock has been given a 'Hold' call, indicating steady performance in the near future.
Shalby Upgraded to 'Hold' Rating by MarketsMOJO, Strong Financials and Positive Technical Indicators Support
Shalby, a smallcap healthcare services company, has been upgraded to a 'Hold' rating by MarketsMOJO due to its low Debt to Equity ratio and bullish technical indicators. The company also has an attractive ROCE and increasing institutional investor interest. However, concerns remain about its long-term growth and recent negative results.
Shalby . Downgraded to 'Sell' by MarketsMOJO Due to Poor Long-Term Growth and Negative Results
Shalby ., a smallcap healthcare services company, has been downgraded to 'Sell' by MarketsMOJO due to its poor long-term growth and negative results in March 2024. The company's debt-equity ratio is at its highest and its technical trend has deteriorated. However, it has a low debt to equity ratio and attractive valuation. Institutional investors have shown interest, but investors should carefully consider the company's performance before investing.
Shalby sees positive movement in stock price, outperforms sector by 7.32%
On June 5th, 2024, Shalby, a smallcap healthcare services company, saw a positive movement in its stock price, gaining 8.73% and outperforming the sector by 7.32%. However, the stock is currently trading lower than its moving averages. According to MarketsMOJO, the stock call for Shalby is 'Sell' based on its performance today and in the past month. Shalby has a strong track record of providing high-quality and affordable healthcare services, making it a trusted name in the industry.
Shalby's Q4 financials show mixed results, with growth in PBT and PAT but increased interest costs
Shalby, a smallcap healthcare services company, has reported a flat financial performance in the quarter ended March 2024. However, there has been a growth in Profit Before Tax and Profit After Tax, as well as net sales. On the other hand, the company's interest cost has increased and its ability to manage interest payments has deteriorated. MarketsMOJO has given a 'Hold' call for Shalby's stock.
Shalby Upgraded to 'Hold' Rating by MarketsMOJO, Strong Financial Position and Bullish Indicators Support Decision
Shalby, a smallcap healthcare services company, has been upgraded to a 'Hold' rating by MarketsMOJO due to its low Debt to Equity ratio and bullish technical indicators. However, the stock is trading at a premium and has shown poor long-term growth. Institutional investors have increased their stake, but investors should carefully consider the company's fundamentals before investing.
MarketsMOJO Downgrades Shalby to 'Sell' Due to Poor Long-Term Growth and Technical Deterioration
Shalby Ltd., a smallcap healthcare services company, was downgraded to 'Sell' by MarketsMOJO on May 3rd, 2024 due to poor long-term growth. The company's net sales and operating profit have only grown at an annual rate of 15.96% and 15.97% respectively over the last 5 years. Technical factors also indicate a bearish trend. Despite a high return in the past year, caution is advised for potential investors.
Shalby Ltd. Stock Sees Decline of -6.27% Amidst Underperformance in Healthcare Sector
Shalby Ltd., a smallcap healthcare services company, experienced a -6.27% decline in its stock price today, continuing its downward trend for the past three days with a total loss of -4.78%. Despite this, the stock's moving averages suggest a positive long-term trend, while short-term indicators show a decline. According to MarketsMOJO, the stock underperformed the Sensex by -2.36% today, but has outperformed it in the past month with a 16.47% return. Based on these factors, MarketsMOJO has given a 'Hold' call for the stock.
Shalby Ltd. sees 7.0% increase in stock price, outperforms market with 'Hold' call from MarketsMOJO
Shalby Ltd., a smallcap healthcare services company, has seen a 7.0% increase in its stock price on April 8th, 2024. The stock has been performing well, gaining for the last 6 consecutive days and rising by 19.18% in that period. It opened with a gain of 3.29% today and is currently higher than its moving averages, indicating a positive trend. MarketsMOJO has a 'Hold' call for the stock, which has also outperformed its sector and the overall market.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}